bioRxiv ScienceSearch

bioRxiv · 10.1101/524462

The reconstitution of body mass index in HIV positive subjects under antiretroviral treatment in Kinshasa

Abstract

ObjectiveWe aimed to evaluate BMI changes in HIV adults subjects in the first year of ART in malaria endemic areas.\n\nMethodsWe used linear regression analysis showing that the change in weight at 12 months (y) in a malaria-endemic area is related to malaria infection at admission and its different episodes as illustrated by equation: y = a + bxi + {varepsilon}, where x is malaria on admission, i refers to episodes of clinical malaria infection during the year, b is the slope, a is a constant and {varepsilon} are confounding factors such as tuberculosis or poor eating habits.\n\nResultsWe found a positive value for b (b = 0.697), and this shows that weight loss at 12 months is correlated with the diagnosis of severe malaria at admission. In other words, severe malaria eliminates the weight gained under ART.\n\nConclusionsO_LIMalaria is the leading cause of weight loss under ART.\nC_LIO_LIImportant recommendation for future:\nC_LI\n\nThis study suggests nutritional education based on local foods containing antioxidants to fight the oxidative stress generated by HIV and stimulated by Plasmodium falciparum during febrile episodes. Oxidative stress is blocked by NADPHase which is a metalloenzyme based on selenium.\n\nThus, to prevent a weight loss or the occurrence of the protein-energy malnutrition among people living with HIV, it is necessary to use the nutritional education.\n\nResumeO_ST_ABSObjectifC_ST_ABSNous voulions evaluer les modifications de lIMC chez les patients VIH adultes au cours de la premiere annee du traitement antiretroviral dans une zone dendemie palustre\n\nMateriel et MethodesNous avons utilise une analyse de regression lineaire montrant que la variation de poids a 12 mois (y) dans une zone dendemie palustre est liee a linfection palustre a ladmission et a ses differents episodes, comme lillustre lequation suivante: y = a + bxi + {varepsilon}, ou x est le paludisme a ladmission, i les episodes de paludisme clinique survenus au cours de lannee, b est la pente, a est une constante et {varepsilon} sont des facteurs de confusion tels que la tuberculose ou de mauvaises habitudes alimentaires..\n\nResultatsNous avons trouve une valeur positive pour b (b = 0,697), ce qui montre que la perte de poids a 12 mois est en correlation avec le diagnostic de paludisme grave a ladmission. En dautres termes, le paludisme grave elimine le poids gagne sous traitement antiretroviral.\n\nConclusionsO_LILe paludisme est la principale cause de perte de poids sous ARV.\nC_LIO_LIRecommandation importante pour lavenir : Cette etude suggere une education nutritionnelle basee sur des aliments locaux contenant des anti-oxydants pour lutter contre le stress oxydatif genere par le VIH et stimule par le Plasmodium falciparum lors des poussees febriles. Le stress oxydatif est bloque par la NADPHase qui est une metalloenzyme a base de selenium. Ainsi, il est necessaire dutiliser leducation nutritionnelle pour prevenir la perte du poids sous ARV.\nC_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tshima, G. K.. 2019-01-18. The reconstitution of body mass index in HIV positive subjects under antiretroviral treatment in Kinshasa. https://doi.org/10.1101/524462

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology